0001209191-17-038905.txt : 20170609
0001209191-17-038905.hdr.sgml : 20170609
20170609163648
ACCESSION NUMBER: 0001209191-17-038905
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170607
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1208
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Fred M
CENTRAL INDEX KEY: 0001331339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 17903397
MAIL ADDRESS:
STREET 1: C/O BEJING MED-PHARM CORPORATION
STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-07
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001331339
Powell Fred M
C/O ANTARES PHARMA, INC.
100 PRINCETON STREET SOUTH, SUITE 300
EWING
NJ
08628
0
1
0
0
Senior Vice President & CFO
Common Stock
2017-06-07
4
A
0
101434
2.66
A
201434
D
Stock Option (right to buy)
2.66
2017-06-07
4
A
0
217725
0.00
A
2027-06-07
Common Stock
217725
217725
D
Represents grant of restricted stock units made under the 2008 Equity Compensation Plan. The shares vest in three equal annual installments.
Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
The options vest in equal quarterly installments over three years from the date of grant.
/s/Keith Muckenhirn as attorney-in-fact for Fred Powell
2017-06-09